相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Volume-Based Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Improve Outcome Prediction in Early-Stage Non-Small Cell Lung Cancer After Surgical Resection
Seung Hyup Hyun et al.
ANNALS OF SURGERY (2013)
Prognostic Value of Whole-Body Total Lesion Glycolysis at Pretreatment FDG PET/CT in Non-Small Cell Lung Cancer
Helen H. W. Chen et al.
RADIOLOGY (2012)
Prognostic Significance of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Operable Primary Breast Cancer
Jahae Kim et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Prognostic Significance of Volume- based Metabolic Parameters by 18F-FDG PET/ CT in Gallbladder Carcinoma
Jang Yoo et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Prognostic Value of Metabolic Tumor Volume Measured by (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma
Seung Hyup Hyun et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications
Ho Yun Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
Marianne Paesmans et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer
Man Ki Chung et al.
CLINICAL CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival
Herbert Decaluwe et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
Brain tumor imaging in clinical trials
J. W. Henson et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer
Robert J. Cerfolio et al.
ANNALS OF THORACIC SURGERY (2008)
A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?
B. Haibe-Kains et al.
BIOINFORMATICS (2008)
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma
Jenny K. Hoang et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer
Paul De Leyn et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Partial-volume effect in PET tumor imaging
Marine Soret et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters
Marinke Westerterp et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role
Hubert Vesselle et al.
CLINICAL CANCER RESEARCH (2007)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)